Characterizing the Mechanism of Doxorubicin Mediated SAT1 Induction in Triple-Negative Breast Cancer

被引:0
|
作者
White, Chloe [1 ]
Liang, Caroline [1 ]
Velenosi, Thomas [1 ]
机构
[1] Univ British Columbia, Vancouver, BC, Canada
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页数:37
相关论文
共 50 条
  • [41] Metastatic Triple-negative Breast Cancer
    Rakha, E. A.
    Chan, S.
    CLINICAL ONCOLOGY, 2011, 23 (09) : 587 - 600
  • [42] Chemoimmunotherapy for Triple-Negative Breast Cancer
    Slomski, Anita
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 320 (24): : 2521 - 2521
  • [43] Pembrolizumab for triple-negative breast cancer
    Stirrups, Robert
    LANCET ONCOLOGY, 2020, 21 (04): : E183 - E183
  • [44] Targeting triple-negative breast cancer
    Peter Kirkpatrick
    Nature Reviews Drug Discovery, 2009, 8 : 21 - 21
  • [45] Targeting triple-negative breast cancer
    Kirkpatrick, Peter
    NATURE REVIEWS DRUG DISCOVERY, 2009, 8 (01) : 21 - 21
  • [46] Pathogenesis of Triple-Negative Breast Cancer
    Derakhshan, Fatemeh
    Reis-Filho, Jorge S.
    ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE, 2022, 17 : 181 - 204
  • [47] Imaging of triple-negative breast cancer
    Dogan, B. E.
    Turnbull, L. W.
    ANNALS OF ONCOLOGY, 2012, 23 : 23 - 29
  • [48] Immunotherapy in triple-negative breast cancer
    Katz, Heather
    Alsharedi, Mohamed
    MEDICAL ONCOLOGY, 2018, 35 (01)
  • [49] An overview of triple-negative breast cancer
    Pankaj Kumar
    Rupali Aggarwal
    Archives of Gynecology and Obstetrics, 2016, 293 : 247 - 269
  • [50] New perspectives in triple-negative breast cancer therapy based on treatments with TGFβ1 siRNA and doxorubicin
    Cristina Alexandra Ciocan-Cȃrtiţă
    Ancuţa Jurj
    Lajos Raduly
    Roxana Cojocneanu
    Alin Moldovan
    Valentina Pileczki
    Laura-Ancuta Pop
    Liviuţa Budişan
    Cornelia Braicu
    Schuyler S. Korban
    Ioana Berindan-Neagoe
    Molecular and Cellular Biochemistry, 2020, 475 : 285 - 299